Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ABT-751 |
Trade Name | |
Synonyms | E7010 |
Drug Descriptions |
ABT-751 is an anti-mitotic agent that binds to tubulin and exhibits anti-cancer activity in preclinical models (PMID: 19398903, PMID: 23670235, PMID: 30367486). |
DrugClasses | Antimicrotubule Agent 14 |
CAS Registry Number | 141430-65-1 |
NCIT ID | C2679 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABT-751 | ABT-751 | 0 | 0 |
ABT-751 + Bevacizumab + Capecitabine + Irinotecan | ABT-751 Bevacizumab Capecitabine Irinotecan | 0 | 0 |
ABT-751 + Fenretinide | ABT-751 Fenretinide | 0 | 0 |